Assembly Biosciences logo
Assembly Biosciences ASMB
$ 15.27 -0.46%

Квартальный отчет 2024-Q3
добавлен 07.11.2024

report update icon

Assembly Biosciences Мультипликаторы 2011-2024 | ASMB

Мультипликаторы по годам Assembly Biosciences

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-1.0 -0.1 -0.5 -3.2 -4.8 -5.5 -20.7 -7.4 -2.8 -2.5 -3.9 -1.3 -2.4

P/S

8.5 - 10.7 2.5 29.2 33.9 98.4 - - - - - -

EPS

-13.4 -23.1 -3 -1.8 -3.7 -4.0 -2.4 -2.6 -1.8 -3.4 -5 -1.9 -3.6

EV (Enterprise Value)

137 млн -28.2 млн 43.6 млн 181 млн 486 млн 517 млн 862 млн 317 млн 68.3 млн 42.4 млн 51.6 млн 14.5 млн 49.7 млн

EBITDA per Share

-14 -23.2 -3.06 -1.8 -3.89 -4.04 -2.93 -2.62 -1.88 -3.42 -5.05 -9.76 -17.7

EV/EBITDA

-0.1 -2.2 -4.1 -5.0 -15.5 -6.6 -1.8 -1.2 -2.5 -0.5 -1.4

PEG

-0.01 -0.0 -0.04 -0.06 -0.73 0.08 -3.33 0.18 -0.06 -0.08 -0.08 -0.03 -0.03

P/B

1.5 0.1 0.4 0.8 1.7 2.4 7.8 4.1 0.7 1.0 3.1 1.8 2.4

P/CF

2.7 -0.1 -0.7 -3.0 -5.4 -7.7 891.7 -9.3 -4.3 -3.9 -4.3 -1.5 -3.4

ROE %

-148.98 -112.61 -76.87 -25.83 -35.73 -43.08 -37.84 -55.41 -23.96 -40.62 -79.22 -139.19 -99.46

ROA %

-44.75 -91.45 -67.97 -21.94 -28.72 -33.86 -25.29 -45.11 -21.27 -33.40 -71.52 -120.60 -92.71

ROCE %

-157.30 -113.85 -78.55 -25.03 -32.56 -37.16 -33.52 -49.76 -22.75 -34.14 -80.04 -139.56 -98.46

Current Ratio

1.4 5.3 8.6 9.2 11.6 12.0 9.1 7.5 20.1 27.7 10.3 7.5 14.7

DSO

25.1 - 45.7 5.7 77.1 59.9 92.0 - - - - - -

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Операционный цикл

25.1 - 45.7 - - - - - - - - - -

Финансовый цикл

25.1 - 45.7 - - - - - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Assembly Biosciences

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-1.51 -1.98 -1.66 - -3.29 -3.88 -4.46 - -0.48 -0.51 -0.48 - -0.41 -0.55 -0.69 -1.11 -0.09 0.21 -0.76 -0.99 -0.96 -0.72 -1.05 -1.03 -0.87 -1.3 -0.8 -160 -710 -780 -810 -0.67 -0.67 -0.59 -0.64 -0.45 -0.38 -0.41 -0.64 - -1.33 -0.52 -0.92 - -1.23 -1.2 -0.22 -0.29 -0.41 -0.59 -0.66 -1.52 -0.5 -0.97 -0.38

EBITDA per Share

- - -1.95 - - - -4.57 - -0.48 -0.5 -0.48 - -0.41 -0.55 -0.68 - -0.1 0.19 -0.79 - -0.99 -0.76 -1.1 - -0.89 -1.31 -0.82 - -0.71 -0.78 -0.8 - -0.68 -0.61 -0.65 - -0.41 -0.42 -0.64 - -1.34 -0.53 -0.93 - -1.24 -1.22 -0.22 - -0.41 -0.59 -0.66 - -0.48 -0.96 -0.21

ROE %

-131.54 -129.14 -127.73 -92.26 -114.86 -102.90 -91.88 -58.06 -66.43 -52.20 -42.65 -29.55 -45.94 -38.96 -25.76 -25.83 -19.36 -27.12 -36.91 -35.73 -38.24 -39.32 -45.27 -43.08 -33.32 -33.95 -33.24 -37.84 -49.64 -53.28 -53.97 -55.41 -47.48 -38.57 -31.70 -23.96 -36.25 -49.49 -47.86 -29.98 -49.91 -51.03 -66.21 -54.53 -75.82 -85.96 -108.50 -139.19 -172.52 -159.25 -137.47 -99.46 -16.80 -20.16 -7.88

ROA %

-54.76 -73.10 -88.81 -76.11 -95.15 -86.27 -77.95 -50.29 -57.84 -46.35 -38.30 -26.31 -40.22 -33.85 -22.28 -21.94 -15.99 -22.17 -30.18 -28.72 -30.52 -31.20 -35.75 -33.86 -25.87 -25.09 -23.12 -25.29 -35.28 -39.82 -42.14 -45.11 -39.14 -32.29 -27.13 -21.27 -30.95 -41.48 -39.75 -24.65 -42.65 -45.17 -59.21 -49.23 -67.67 -75.73 -94.56 -120.60 -153.07 -142.67 -125.12 -92.71 -15.66 -18.79 -7.35

ROCE %

- - - - -22.85 -45.70 -65.52 -58.45 -66.85 -52.40 -42.79 -29.64 -31.31 -24.58 -11.63 -10.45 -19.96 -27.80 -37.75 -27.10 -36.14 -35.67 -39.29 -26.49 -34.48 -33.42 -31.30 -25.64 -38.47 -43.32 -46.10 -36.72 -42.18 -34.81 -28.81 -16.48 -32.23 -42.52 -40.61 -26.34 -46.48 -50.87 -66.93 -55.16 -85.31 -95.33 -117.68 -118.13 -134.19 -120.09 -98.09 -43.77 -16.06 -19.99 -7.72

Current Ratio

1.4 1.4 1.4 1.4 5.2 5.7 6.5 5.3 6.4 7.4 10.2 8.6 10.2 8.6 8.8 6.6 6.6 6.6 6.6 5.1 5.1 5.1 5.1 4.7 4.7 4.7 4.7 3.0 3.0 3.0 3.0 5.4 5.4 5.4 5.4 8.9 8.9 8.9 8.9 5.6 5.6 5.6 5.6 10.3 10.3 10.3 10.3 7.5 7.5 7.5 7.5 14.7 31.3 17.7 -

DSO

- - 0.7 - - - - - - - - - 7.8 - - 108.2 3.2 2.9 51.5 64.6 72.8 100.0 68.2 59.4 51.7 68.9 60.2 62.6 78.0 87.9 151.6 - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

- - 0.7 - - - - - - - - - 7.8 - - 108.2 3.2 2.9 51.5 64.6 72.8 100.0 68.2 59.4 51.7 68.9 60.2 62.6 78.0 87.9 151.6 - - - - - - - - - - - - - - - - - - - - - - - -

Финансовый цикл

- - 0.7 - - - - - - - - - 7.8 - - 108.2 3.2 2.9 51.5 64.6 72.8 100.0 68.2 59.4 51.7 68.9 60.2 62.6 78.0 87.9 151.6 - - - - - - - - - - - - - - - - - - - - - - - -

Все данные представлены в валюте USD